USPTO trademark

EURPHONSA

AllowedUSPTOWord markClass 5

"EURPHONSA" is a word mark owned by Eli Lilly and Company, filed at the USPTO on November 12, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

View Eli Lilly and Company portfolioGet this data via the API
Official USPTO record
EURPHONSA trademark as filed
As filed with the USPTO
Status
Allowed
Since June 9, 2026
Filed
November 12, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99493140
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns EURPHONSA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Eli Lilly and Company

LLY · Indianapolis, United States

89 trademarks in the portfolioView company

Representative

Tiffany Trunko

Eli Lilly and Company

Goods and services

What the mark covers

The products and services EURPHONSA is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Covid-19 disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, weight management, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, peripheral arterial disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Noa e-mailed - sou required from applicant
  2. Teas change of correspondence received
  3. Attorney/dom.rep.revoked and/or appointed
  4. Teas revoke/app/change addr of atty/dom rep received
  5. Official gazette publication confirmation e-mailed
  6. Published for opposition
  7. Notification of notice of publication e-mailed
  8. Approved for pub - principal register
  9. Assigned to examiner
  10. New application office supplied data entered

2 earlier steps on the official record.

FAQ

About EURPHONSA

Who owns the trademark "EURPHONSA"?

The USPTO trademark "EURPHONSA" (application 99493140) is owned by Eli Lilly and Company.

What is the status of "EURPHONSA"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull EURPHONSA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b5c-13e6-72cd-9aae-7e3b4bd859c8
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b5c-13e6-72cd-9aae-7e3b4bd859c8",
  "object": "trademark",
  "mark_text": "EURPHONSA",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99493140",
  "filing_date": "2025-11-12",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Eli Lilly and Company",
      "entity_id": "ent_019f286c-97ee-774b-84b5-808f427dcf3e"
    }
  ]
}